Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-14
2010-11-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S248000
Reexamination Certificate
active
07834040
ABSTRACT:
The present invention relates to new pharmaceutical uses of an isoxazolic derivative or a pharmaceutically acceptable salt thereof in the preparation of a medicament useful for treating the neuropathic pain.
REFERENCES:
patent: 4985428 (1991-01-01), Carenzi et al.
patent: WO 88/09330 (1988-12-01), None
Rashid et al, The Journal of pharmacology and experimental therapeutics, vol. 303, 2002, pp. 226-231.
S. Ricciardi, et al., Behavioural and Biochemical Effects of a New. . . , J. Drug Dev., vol. 6, No. 4, pp. 159-170, 1994.
S. Ricciardi, et al., Z-4105, Drugs of the Future, vol. 20, No. 6, pp. 584-586, 1995.
Moriggi Ermanno
Napoletano Mauro
Lucas & Mercanti LLP
Saeed Kamal A
Zambon S.p.A.
LandOfFree
Isoxazolic derivative to relieve neuropathic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazolic derivative to relieve neuropathic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazolic derivative to relieve neuropathic pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243367